Literature DB >> 1847171

Engagement of MHC-class II molecules by staphylococcal exotoxins delivers a comitogenic signal to human B cells.

R Fuleihan1, W Mourad, R S Geha, T Chatila.   

Abstract

The staphylococcal exotoxin toxic shock syndrome toxin-1 (TSST-1) has been demonstrated to bind to monomorphic determinants on MHC-class II molecules. In this study, we have used TSST-1 to probe the role of MHC-class II molecules in the activation and differentiation of resting human B cells. Highly purified B cells were stimulated with TSST-1, alone or in combination with PMA or with anti-human IgM antibodies (anti-mu) and the resulting B cell proliferation and Ig production were monitored. On its own, TSST-1 failed to induce B cell proliferation or Ig production. However, TSST-1 synergized with PMA and with anti-mu in inducing B cell proliferation in the absence of any added T cells or T cell factors. TSST-1 did not induce or potentiate early activation events associated with anti-mu treatment such as phosphoinositide hydrolysis and Ca2+ mobilization. Also, TSST-1 did not potentiate the capacity of anti-mu to induce the transcription of early activation genes such as c-myc. Finally, in contrast to its capacity to promote mitogen-trigered B cell proliferation, TSST-1 failed to induce the differentiation of B lymphocytes into Ig-secreting cells in the absence of added T cells. These results indicate that TSST-1 delivers a comitogenic signal to B cells via MHC-class II molecules that is distinct from signals delivered via surface mu and further strengthens the role of MHC-class II molecules as signal transducing structures.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847171

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.

Authors:  K Matsubara; T Fukaya; K Miwa; N Shibayama; H Nigami; H Harigaya; H Nozaki; T Hirata; K Baba; T Suzuki; A Ishiguro
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

Review 2.  Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis.

Authors:  B Henderson; S Poole; M Wilson
Journal:  Microbiol Rev       Date:  1996-06

Review 3.  Superantigens related to B cell hyperplasia.

Authors:  N M Ponzio; V K Tsiagbe; G J Thorbecke
Journal:  Springer Semin Immunopathol       Date:  1996

Review 4.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

5.  Mycoplasma arthritidis mitogen up-regulates human NK cell activity.

Authors:  J A D'Orazio; B C Cole; J Stein-Streilein
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

6.  Localization of binding sites of staphylococcal enterotoxin B (SEB), a superantigen, for HLA-DR by inhibition with synthetic peptides of SEB.

Authors:  J L Komisar; S Small-Harris; J Tseng
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

7.  Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis.

Authors:  M F Hofer; K Newell; R C Duke; P M Schlievert; J H Freed; D Y Leung
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

8.  Staphylococcal exotoxins deliver activation signals to human T-cell clones via major histocompatibility complex class II molecules.

Authors:  F Spertini; H Spits; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

9.  Selective induction of rheumatoid factors by superantigens and human helper T cells.

Authors:  X W He; J Goronzy; C Weyand
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

Review 10.  Modulins: a new class of cytokine-inducing, pro-inflammatory bacterial virulence factor.

Authors:  B Henderson; M Wilson
Journal:  Inflamm Res       Date:  1995-05       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.